Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of hematological disorders
3.2.1.2 Advancements in transplantation techniques
3.2.1.3 Rising investments in research and development
3.2.1.4 Growing pipeline of therapeutic agents
3.2.2 Industry pitfalls & challenges
3.2.2.1 High treatment cost
3.2.2.2 Stringent regulatory challenges
3.2.2.3 Risk of complications and relapse
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Million)
5.1 Key trends
5.2 Acute graft versus host disease (aGVDH)
5.3 Chronic graft versus host disease (cGVDH)
Chapter 6 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Million)
6.1 Key trends
6.2 Monoclonal antibodies
6.3 mTOR inhibitors
6.4 Tyrosine kinase inhibitors
6.5 Immunosuppressants
6.6 Corticosteroids
6.7 Other treatment types
Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Million)
7.1 Key trends
7.2 <20 years
7.3 21-50 years
7.4 51 years and above
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Million)
8.1 Key trends
8.2 Oral
8.3 Intravenous
8.4 Topical
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Million)
9.1 Key trends
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Astellas Pharma Inc.
11.2 Bristol Myers Squibb
11.3 ElsaLys Biotech SA
11.4 Incyte Corporation
11.5 Johnson & Johnson Services, Inc.
11.6 Kiadis Pharma
11.7 Mallinckrodt Pharmaceuticals
11.8 Merck & Co., Inc.
11.9 Mesoblast Ltd
11.10 Neovii Pharmaceuticals AG
11.11 Novartis AG
11.12 Pfizer Inc.
11.13 Sanofi
11.14 Soligenix
